These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 35689600)

  • 21. Skewed Cytokine Responses Rather Than the Magnitude of the Cytokine Storm May Drive Cardiac Dysfunction in Multisystem Inflammatory Syndrome in Children.
    Chang JC; Matsubara D; Morgan RW; Diorio C; Nadaraj S; Teachey DT; Bassiri H; Behrens EM; Banerjee A
    J Am Heart Assoc; 2021 Aug; 10(16):e021428. PubMed ID: 34365798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-6, CXCL10 and Infiltrating Macrophages in COVID-19-Related Cytokine Storm: Not One for All But All for One!
    Coperchini F; Chiovato L; Rotondi M
    Front Immunol; 2021; 12():668507. PubMed ID: 33981314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of "inflame-aging".
    Meftahi GH; Jangravi Z; Sahraei H; Bahari Z
    Inflamm Res; 2020 Sep; 69(9):825-839. PubMed ID: 32529477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of Exaggerated Cytokine Production in Human Peripheral Blood Mononuclear Cells by a Recombinant SARS-CoV-2 Spike Glycoprotein S1 and Its Inhibition by Dexamethasone.
    Olajide OA; Iwuanyanwu VU; Lepiarz-Raba I; Al-Hindawi AA
    Inflammation; 2021 Oct; 44(5):1865-1877. PubMed ID: 33860869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wharton's Jelly Mesenchymal Stem Cell-Derived Extracellular Vesicles Reduce SARS-CoV2-Induced Inflammatory Cytokines Under High Glucose and Uremic Toxin Conditions.
    Khanh VC; Fukushige M; Chang YH; Hoang NN; Yamashita T; Obata-Yasuoka M; Hamada H; Osaka M; Hiramatsu Y; Ohneda O
    Stem Cells Dev; 2021 Aug; 30(15):758-772. PubMed ID: 34074129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repurposing of drugs targeting the cytokine storm induced by SARS-CoV-2.
    Ng WH; Tang PCH; Mahalingam S; Liu X
    Br J Pharmacol; 2023 Jan; 180(2):133-143. PubMed ID: 36394425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytokine storm and histopathological findings in 60 cases of COVID-19-related death: from viral load research to immunohistochemical quantification of major players IL-1β, IL-6, IL-15 and TNF-α.
    Frisoni P; Neri M; D'Errico S; Alfieri L; Bonuccelli D; Cingolani M; Di Paolo M; Gaudio RM; Lestani M; Marti M; Martelloni M; Moreschi C; Santurro A; Scopetti M; Turriziani O; Zanon M; Scendoni R; Frati P; Fineschi V
    Forensic Sci Med Pathol; 2022 Mar; 18(1):4-19. PubMed ID: 34463916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytokine storm and translating IL-6 biology into effective treatments for COVID-19.
    Li T; Wang D; Wei H; Xu X
    Front Med; 2023 Dec; 17(6):1080-1095. PubMed ID: 38157195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis.
    Ramasamy S; Subbian S
    Clin Microbiol Rev; 2021 Jun; 34(3):. PubMed ID: 33980688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pentoxifylline and Oxypurinol: Potential Drugs to Prevent the
    López-Iranzo FJ; López-Rodas AM; Franco L; López-Rodas G
    Curr Pharm Des; 2020; 26(35):4515-4521. PubMed ID: 32787748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients.
    Olbei M; Hautefort I; Modos D; Treveil A; Poletti M; Gul L; Shannon-Lowe CD; Korcsmaros T
    Front Immunol; 2021; 12():629193. PubMed ID: 33732251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging aspects of cytokine storm in COVID-19: The role of proinflammatory cytokines and therapeutic prospects.
    Dharra R; Kumar Sharma A; Datta S
    Cytokine; 2023 Sep; 169():156287. PubMed ID: 37402337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The roles of critical pro-inflammatory cytokines in the drive of cytokine storm during SARS-CoV-2 infection.
    Qudus MS; Tian M; Sirajuddin S; Liu S; Afaq U; Wali M; Liu J; Pan P; Luo Z; Zhang Q; Yang G; Wan P; Li Y; Wu J
    J Med Virol; 2023 Apr; 95(4):e28751. PubMed ID: 37185833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CIGB-258, a peptide derived from human heat-shock protein 60, decreases hyperinflammation in COVID-19 patients.
    Hernandez-Cedeño M; Venegas-Rodriguez R; Peña-Ruiz R; Bequet-Romero M; Santana-Sanchez R; Penton-Arias E; Martinez-Donato G; Guillén-Nieto G; Dominguez-Horta MDC
    Cell Stress Chaperones; 2021 May; 26(3):515-525. PubMed ID: 33629254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Huashibaidu formula attenuates sepsis-induced acute lung injury via suppressing cytokine storm: Implications for treatment of COVID-19.
    Zhang F; Guo F; Zhang Y; Xu H; Liu Y; Lin L; Li H; Yang H; Huang L
    Phytomedicine; 2023 Jan; 109():154549. PubMed ID: 36610129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discrimination of COVID-19 From Inflammation-Induced Cytokine Storm Syndromes Using Disease-Related Blood Biomarkers.
    Kessel C; Vollenberg R; Masjosthusmann K; Hinze C; Wittkowski H; Debaugnies F; Nagant C; Corazza F; Vély F; Kaplanski G; Girard-Guyonvarc'h C; Gabay C; Schmidt H; Foell D; Tepasse PR
    Arthritis Rheumatol; 2021 Oct; 73(10):1791-1799. PubMed ID: 33880885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytokine Drizzle-The Rationale for Abandoning "Cytokine Storm".
    Stolarski AE; Kim J; Zhang Q; Remick DG
    Shock; 2021 Nov; 56(5):667-672. PubMed ID: 34652339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytokine Signature Induced by SARS-CoV-2 Spike Protein in a Mouse Model.
    Gu T; Zhao S; Jin G; Song M; Zhi Y; Zhao R; Ma F; Zheng Y; Wang K; Liu H; Xin M; Han W; Li X; Dong CD; Liu K; Dong Z
    Front Immunol; 2020; 11():621441. PubMed ID: 33584719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is COVID-19-associated cytokine storm distinct from non-COVID-19 secondary hemophagocytic lymphohistiocytosis?
    Liu JM; Chi J
    Exp Biol Med (Maywood); 2022 Feb; 247(4):330-337. PubMed ID: 35068219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Laboratory Biomarkers in the Management of Patients With COVID-19.
    Weidmann MD; Ofori K; Rai AJ
    Am J Clin Pathol; 2021 Feb; 155(3):333-342. PubMed ID: 33107558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.